TheraCare 4% Lidocaine and 1% Menthol Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
TheraCare 4% Lidocaine and 1% Menthol Cream
Generic name
MENTHOL AND LIDOCAINE
Manufacturer
Veridian Healthcare
Product type
HUMAN OTC DRUG
SPL set ID
c80ba251-91a5-0858-e053-2995a90a9cff
SPL ID
18fad642-24ee-746c-e063-6294a90ae791
Version
3
Effective date
2024-05-21
Source export date
2026-10-30
Source partition
11
Source file
https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-30/9abf0f8b126f8aad070e21ea702bfb5e39ce670b16ae57dd52e8877705d1bf5d/drug-label-0011-of-0014.json.zip
Source manifest SHA-256
b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run
20261102T182004Z
Imported at
2026-11-02 19:25:51
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Avoid contact with eyes Do not use ■ on large areas of the body or on cut, irritated or swollen skin ■ on puncture wounds ■ for more than one week without consulting a doctor When using this product ■ use only as directed. Read and follow all directions and warnings on this carton. ■ do not allow contact with the eyes ■ do not bandage or apply local heat (such as heating pads) to the area of use Stop use and ask a doctor if ■ condition worsens ■ symptoms persist for more than 7 days or clear up and occur again within a few days If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (800-222-1222) right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.